A Review of Human and Analogue Insulin Trials.
From: Institute of Biomedical Research, The Medical School, University of Birmingham, Birmingham, UK. s.c.gough@bham.ac.uk
Diabetes research and clinical practice
- Publish Date: Jul 2007
- ISSN: 0168-8227
- Volume: 77
- Issue: 1
- Pages: 1-15
- Medium: Print
- Language: English
- Citation (JAMA): Gough Stephen C L, et al. A Review of Human and Analogue Insulin Trials.. Diabetes Res. Clin. Pract. Jul 2007;77:1-15
Abstract
A recent meta-analysis evaluated trials of the rapid-acting analogues insulin lispro and insulin aspart, performed before the introduction of the basal analogues, insulin glargine and insulin detemir. This article reviews the effect of rapid-acting and basal insulin analogues separately and in combination, relative to human insulin. Outcomes evaluated include HbA(1c), hypoglycaemia, postprandial glucose (PPG), and weight changes. Results from trials that matched defined criteria are presented in tables. In type 1 diabetes, compared with human insulin, the rapid-acting analogues generally reduced hypoglycaemia and postprandial glucose, whereas the basal analogues tended to reduce hypoglycaemia — particularly nocturnal hypoglycaemia. Weight gain may also be reduced with basal analogues, compared with human basal insulin. In type 2 diabetes, premix rapid-acting analogues controlled postprandial glucose better than human insulin mixes; basal analogues used as basal-only therapy reduced hypoglycaemia compared with NPH insulin; and some advantages were apparent with analogues in basal-bolus therapy. Whilst the benefits on individual metabolic and clinical outcomes appear modest, almost all studies report some advantage when using insulin analogues in type 1 and type 2 diabetes. Significant benefits, including PPG lowering with the rapid-acting analogues and the potential for reduction in cardiovascular risk, should be investigated further.
Mesh Headings (Keywords): Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Drug Administration Schedule, Hemoglobin A, Glycosylated, Humans, Hypoglycemia, Insulin, Insulin, Isophane, Postprandial Period, Randomized Controlled Trials as Topic
Check for Full Text / PubMed Unique Identifier (PMID): 17112621
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.